tDCS for Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new approach to aid stroke survivors using cerebellar tDCS (transcranial direct current stimulation), which sends a small electrical current to the brain. The main goal is to determine the duration of the treatment's effects and its impact on brain activity, thinking, language, and movement. Researchers will divide participants into three groups to receive different types of stimulation or a sham (inactive) treatment. The trial seeks healthy adults who can see and hear well, read, and use a keyboard. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research in stroke recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that cerebellar tDCS is safe for individuals with unilateral cortical stroke?
Research has shown that cerebellar transcranial direct current stimulation (tDCS) is generally safe. This technique sends a small electrical current to the brain and has improved movement in stroke patients. The treatment is usually well-tolerated, with only mild side effects. Some individuals have experienced minor issues such as headaches, tiredness, a burning sensation under the electrodes, or dizziness. Importantly, no serious side effects have been linked to cerebellar tDCS, suggesting it is a safe option for those considering participation in a clinical trial with this therapy.12345
Why are researchers excited about this trial?
Unlike traditional stroke treatments that typically rely on medications or physical therapy, cerebellar transcranial Direct Current Stimulation (tDCS) offers a novel approach by using electrical currents to stimulate the brain. Researchers are excited about this technique because it targets the cerebellum, a part of the brain crucial for motor control and coordination, potentially enhancing recovery in ways standard therapies don't. This non-invasive method is unique because it can be precisely controlled and targeted, providing a customizable treatment experience that might enhance neuroplasticity and accelerate rehabilitation.
What evidence suggests that cerebellar tDCS could be effective for stroke recovery?
Research shows that cerebellar transcranial direct current stimulation (tDCS) can help stroke patients improve movement and speech. In this trial, participants will be randomized into groups to receive either real anodal tDCS, real cathodal tDCS, or a sham treatment. Previous studies have shown that anodal tDCS on the cerebellum, combined with speech therapy, enhanced language skills. Another study found that cathodal tDCS with speech therapy improved language abilities in individuals with post-stroke speech difficulties. Additionally, tDCS has aided in the recovery of arm and hand movements, crucial for everyday tasks. These findings suggest that cerebellar tDCS may benefit stroke recovery.14678
Who Is on the Research Team?
Sharyl Samargia-Grivette
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've had a stroke. Participants need good vision to see a computer screen, fine motor skills to use a keyboard, and hearing to follow directions. They must be able to read and understand English fluently.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive cerebellar tDCS and are assessed for cortical excitability, cognitive, language, and motor performance at baseline, 15, 45, and 75 minutes post-tDCS
Follow-up
Participants are monitored for any delayed effects of tDCS and safety
What Are the Treatments Tested in This Trial?
Interventions
- Cerebellar tDCS
Cerebellar tDCS is already approved in United States, European Union for the following indications:
- Stroke rehabilitation
- Aphasia treatment
- Motor function recovery
- Stroke rehabilitation
- Aphasia treatment
- Motor function recovery
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor